Breast implant-associated anaplastic large cell lymphoma is a newly recognized provisional
entity in the 2017 revision of the World Health Organization Classification of Tumors of …

Breast implant-associated anaplastic large cell lymphoma (BIA ALCL) is a newly described
clinicopathologic entity. The purpose of this study is to describe the imaging findings of …

Purpose Breast implant–associated anaplastic large-cell lymphoma (BI-ALCL) is a rare type
of T-cell lymphoma that arises around breast implants. The optimal management of this …

Purpose Breast implant–associated anaplastic large-cell lymphoma (ALCL) is a recently
described clinicopathologic entity that usually presents as an effusion-associated fibrous …

Abstract Session 2 of the 2018 European Association of Hematopathology/Society for
Hematopathology Workshop focused on lymphomas arising in immune-privileged sites: both …

Background: In recent years, there have been growing concerns about a possible
association of non-Hodgkin's lymphoma—in particular, anaplastic large cell lymphoma …

Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a distinct type of T-
cell lymphoma arising around breast implants. The United States FDA recently updated the …

Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a rare T-cell
lymphoma that arises around breast implants. Most patients manifest with periprosthetic …

In 2011, the United States Food and Drug Administration (FDA) published a safety
communication stating,“Women with breast implants may have a very small but increased …

Background: The goal of this consensus is to establish an algorithm for the management of
patients who develop a late or delayed periprosthetic fluid collection. A work group of …